FDA Approved Add-On Treatment For Patients With Parkinson’s Disease
According to the National Institutes of Health (NIH), about one million of people in the United States have Parkinson’s disease and about 60,000 people are…
Products
For $14,000 a Year, Cholesterol Drug Repatha (evolocumab) Lowers the Risk of a Heart Attack
People who are at high risk of heart attack or stroke now have a new drug that can decrease the risk of the mentioned health…
FDA Approves House Dust Mite Allergies Treatment Odactra
On March 1, the Food and Drug Administration (FDA) approved Odactra, a drug developed to treat house dust mite (HDM) allergies. The medication is manufactured…
Spinal Muscular Atrophy Drug Approval
Spinraza was developed by Ionis Pharmaceuticals of Carlsbad in partnership with Biogen Inc. In July 2016, Biogen decided to license Spinraza. During Spinraza’s development, Ionis…
Unreasonable Insulin Price Boost
Insulin, a life-saving drug, was invented about a hundred years ago. For the past 20 years, the price for insulin has been steadily increasing. Now,…
Painkiller Approval By The FDA
According to the Centers for Disease Control and Prevention, about 15,000 people die each year from overdoses caused by prescription medication. Painkillers are the top…
Another Weight-Loss Drug Approval For The Last Month
Another medication, called Qsymia, designed for obesity treatment and considered to be the most effective among the new generation of weight-loss drugs, was approved by…
First Approved Weight-Loss Medication In 13 Years
Belviq, the first new medications for weight loss that was released on the U.S. market for more than ten years, was approved by the U.S….
Experts Are Concerned With The New Strong Painkiller
Said to be ten times stronger than Vicodin, another painkiller is in its final development stages. Four companies have begun testing of their medications on…
Lucentis And Avastin Effectiveness In Treating Macular Degeneration
Age-related macular degradation (AMD) is the most common reason for vision loss or blindness in senior U.S. citizens. This disease spurs the growth of uncommon…